Balloon Catheters Market Size
The Global Balloon Catheters Market size was valued at US 4.58 billion in 2022 and is estimated to reach US 8.65 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).
The balloon catheter is a flexible and delicate catheter device type with a balloon-like, attached at its tip. This balloon can be inflated or deflated when the catheter is in place to enlarge or create a passageway. Balloon Catheters are primarily used to treat heart-related diseases, specifically coronary heart disease caused due to diabetes, high cholesterol levels in the blood, and high blood pressure.
Market Summary
| Metrics | Details |
| Market CAGR | 8.7% |
| Segments Covered | By Product Type, By Material Type, By Disease Indication, By End User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Request Free Sample
Market Dynamics
The growth of the market is majorly driven by increasing incidences of cardiac diseases, the rising geriatric population, the growing demand for minimally invasive surgery, and increasing government initiatives like favorable reimbursement policies.
Increasing incidences of cardiac diseases coupled with technological advancements are expected to drive market growth
According to Coronary Artery Disease among Asian Indians (CADI) Research Foundation, around 60,000 coronary artery bypass surgery performed every year in India. Asian Indians constitute a fifth of the global population and have been noted to have the highest coronary artery disease (CAD) rates. The number of coronary artery bypass surgeries will keep rising due to the increasing geriatric population with diabetes and high blood cholesterol levels.
Furthermore, technological advancements have resulted in the development of innovative products, giving better outcomes. For instance, in April 2021, Cardiovascular Systems launched innovative peripheral balloon catheters for complex lesions. In addition, companies are investing in research on new technologies and their safety studies and receiving support from the governments for analysis. For instance, in April 2022, Terumo Corporation released the first patient enrolment for the study on its latest bobby balloon guide catheter.
The high cost associated with the treatment is one of the major factors hindering the growth of the market
The expensive cost of sophisticated catheters could limit industry expansion. In addition, a growing proportion of patients undergoing catheterization need innovative catheters because they have chronic and cardiovascular disorders like urine bladder, renal failure, and coronary heart disease. However, the adoption rate of catheters may decline throughout low-income countries due to the expensive catheterization operations for these disorders.
The high price of these gadgets and necessary accessories could limit market expansion. In addition, market growth in underdeveloped nations with relatively low-income levels may be constrained because of the high costs involved with catheterization procedures. As a result, it might be challenging for middle-income and low-income countries to adopt such expensive goods. Therefore, the high price of these advanced devices could restrain the expansion of the catheter market over the estimated year.
COVID-19 Impact on Market
Due to on-hold services, such as treatment, diagnostic, and surgical services, to stop the spread of COVID-19 disease, it is projected that the COVID-19 epidemic will have a short-term negative impact on the growth of the global catheter industry. Jordan implemented a severe COVID-19-related lockout, according to the National Library of Medicine. Cardiovascular catheterization procedure volumes drastically decreased during the rigorous lockdown and gradually increased following a partial relaxation of the lockdown. However, as the government and healthcare organizations continue to enhance medical care for COVID-19 patients, catheters will be utilized more frequently in hospitals. Catheters are being used to treat patients whose COVID-19 diagnoses were verified.
Industry Analysis
The global balloon catheters market provides an in-depth analysis of the market based on various industry factors such as porter’s five forces, regulatory analysis, reimbursement analysis, supply chain analysis, pricing analysis, technological advancements, etc.
Market Segmentation
Drug-eluting balloon catheters segment is expected to hold the largest market share in the global balloon catheters market
The segment is growing due to the growing usage of drug-eluting balloons in the treatment of peripheral artery diseases as these devices are easy to use and the treatment shows an improved patency rate as compared to that of standard PTA balloons. In addition, the growth of the peripheral drug-eluting balloon segment is attributed to the increasing development of these devices by major players.
The coronary drug-eluting balloon segment is anticipated to register an above-average growth rate during the forecast period despite the predominant use of drug-eluting stents in coronary interventions. A rise in preference for drug-eluting balloons for coronary interventions has been observed among physicians as these devices have the potential to eradicate the risk of stent failure and show higher efficiency than drug-eluting stents. Additionally, anticipated product launches by Boston Scientific and Concept, Medical, Inc. are likely to drive the coronary drug-eluting balloon segment during the forecast period. For instance, In 2021, Medtronic plc launched the Prevail drug-coated balloon (DCB) Catheter in Europe for treating coronary artery disease.
Market Geographical Share
North America region holds the largest market share in the global balloon catheters market
This large revenue share is mainly due to the rising prevalence of urological illnesses, renal failure, and the abundance of highly qualified surgeons, among other things. For instance, every seventh adult in the United States, or more than 37 million people, is projected to have chronic kidney disease, according to estimates from the Centers for Disease Control and Prevention (CDC). It is anticipated that the rising prevalence of diseases would increase the demand for catheterization operations, which employ these devices. The American Urological Association (AUANET) estimates that there will be 13,352 urologists working full-time in the United States in 2020. Additionally, it is anticipated that rising cardiac catheterization hospitalizations will promote market expansion in the nation. For instance, the NCBI estimates that more than 1,000,000 cardiac catheterization operations are carried out each year in the United States. Major players' presence in the area will also increase consumer demand and adoption rates for the products. Therefore, it is anticipated that the aforementioned causes will increase demand for catheterization procedures.
Companies and Competitive Landscape
Some of the key players in the global Balloon Catheters market are Biomerics, Boston Scientific Corporation, A.V medical, Teleflex Medical, Johnson & Johnson, Medtronic, Inc, MicroPort Scientific Corporation, Vascular Solutions, Inc, Abbott Laboratories, BIOTRONIK SE & Co. KG, Nordson.
Key Companies to Watch
Medtronic Plc:
Overview: Medtronic plc is an American company that operates in the U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.
Product Portfolio: EUPHORIA SEMICOMPLIANT BALLOON CATHETER
The global balloon catheters market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.
